Spire Wealth Management’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.2K | Sell |
227
-146
| -39% | -$5.92K | ﹤0.01% | 1747 |
|
|
2025
Q1 | $19.2K | Buy |
373
+230
| +161% | +$11.8K | ﹤0.01% | 1625 |
|
|
2024
Q4 | $7.92K | Sell |
143
-84
| -37% | -$4.65K | ﹤0.01% | 1906 |
|
|
2024
Q3 | $7.47K | Sell |
227
-33
| -13% | -$1.09K | ﹤0.01% | 1722 |
|
|
2024
Q2 | $7.07K | Buy |
260
+127
| +95% | +$3.45K | ﹤0.01% | 1742 |
|
|
2024
Q1 | $4.84K | Buy |
133
+67
| +102% | +$2.44K | ﹤0.01% | 1936 |
|
|
2023
Q4 | $1.55K | Sell |
66
-80
| -55% | -$1.88K | ﹤0.01% | 2193 |
|
|
2023
Q3 | $2.59K | Hold |
146
| – | – | ﹤0.01% | 2076 |
|
|
2023
Q2 | $2.64K | Buy |
146
+43
| +42% | +$777 | ﹤0.01% | 2145 |
|
|
2023
Q1 | $1.3K | Buy |
+103
| New | +$1.3K | ﹤0.01% | 2355 |
|
|
2022
Q3 | – | Sell |
-50
| Closed | -$1K | – | 2570 |
|
|
2022
Q2 | $1K | Sell |
50
-50
| -50% | -$1K | ﹤0.01% | 2578 |
|
|
2022
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 2420 |
|
|
2021
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 2802 |
|
|
2021
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 2486 |
|
|
2021
Q2 | $3K | Hold |
100
| – | – | ﹤0.01% | 2436 |
|
|
2021
Q1 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 2777 |
|